Market Closed -
Other stock markets
|
After market 03:58:14 pm | |||
17.64 EUR | +0.34% | 17.7 | +0.34% |
Apr. 11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
Apr. 11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.20% | 1.37B | B | ||
+24.17% | 562B | B | ||
-6.33% | 358B | C+ | ||
+19.90% | 322B | B- | ||
+7.95% | 297B | C+ | ||
+13.45% | 219B | B+ | ||
+6.04% | 199B | B- | ||
-10.51% | 196B | A+ | ||
-12.26% | 149B | C+ | ||
-6.47% | 146B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FAGR Stock
- Ratings Fagron N.V.